Corporate News Report

Company: Hydration Pharmaceuticals Co Ltd (HPC.AX)Reporting Period: 24‑hour window ending 04:36 PM Central Europe, Friday 23 March 2026

ItemDetail
Current Trading PriceAUD 0.01
Price Change (24 h)0 % (flat)
Trading Volume (last 24 h)AUD 180
Market CapitalisationAUD 1.1 million
Shares Outstanding538 million
Simple Moving Average (200 days)AUD 0
52‑Week HighAUD 0.01 (11 June 2025)
52‑Week LowAUD 0 (22 October 2026)
Price Change Since Last Month‑End0 % (flat)
TickerPrice (current)Price ChangeMarket Cap
Wingara (WNR.AX)AUD 0.010 %AUD 924.5 k
Mcs Services (MSG.AX)AUD 00 %AUD 535.6 k
Australia United Mining (AYM.AX)AUD 0100 %AUD 1.3 mn
Multistack (MSI.AX)AUD 00 %AUD 408.9 k
Queste Communications (QUE.AX)AUD 0.050 %AUD 907.8 k

Queste Communications Specifics

  • P/E Ratio: 52.63
  • Corporate Governance: Maintains active participation in a group of companies managed by Farooq Khan and other directors.
  • Operational Focus: Telecommunications and information‑technology services, with oversight of related resource and mining ventures.
  • Recent Disclosures: No operational or financial changes; no new capital or dividend decisions announced.
  • Strategic Position: Activities remain aligned with existing strategic priorities; no material deviations from established corporate governance or compliance policies.

Company Profile – Hydration Pharmaceuticals Co Ltd

Hydration Pharmaceuticals Co Ltd is a listed pharmaceutical company operating within Australia’s consumer staples sector. The company’s activities revolve around the development, manufacturing, and distribution of pharmaceutical products aimed at consumer health and well‑being.